Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials

Yinan Zhang,Natalia Gonzalez Caldito,Afsaneh Shirani,Amber Salter,Gary Cutter,William J. Culpepper,Mitchell T. Wallin,Peter Kosa,Bibiana Bielekova,Fred D. Lublin,Olaf Stϋve

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials

2020

Yinan Zhang
Natalia Gonzalez Caldito
Afsaneh Shirani
Amber Salter
Gary Cutter
William J. Culpepper
Mitchell T. Wallin
Peter Kosa
Bibiana Bielekova
Fred D. Lublin
Olaf Stϋve

Background:Disease-modifying therapies (DMTs) for multiple sclerosis (MS) are approved for the treatment of disease activity and are effective in reducing relapses and new magnetic resonance imagin...

Keywords:

Magnetic resonance imaging
disease activity
Meta-analysis
Multiple sclerosis
Internal medicine
Oncology
Disease
Medicine
Clinical trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations